OBJECTIVE: To evaluate the treatment effect of collagenase Clostridium histolyticum (CCH) in a rat model of urethral fibrosis. MATERIALS AND METHODS: Thirty male Sprague-Dawley rats (300-350 g) were divided into 5 groups. The rat urethra was injected with normal saline in the sham group and, in the other 4 groups, the rat urethra was injected with 10 μg of transforming growth factor beta 1 to create fibrosis of the urethra. Two weeks following transforming growth factor beta 1 injection, the rats were injected with varying doses of CCH or vehicles, depending on their group. The rats were then euthanized at 4 weeks after CCH or vehicle injection. Urethral tissue was harvested for histologic and molecular analyses. Type I and III collagen levels were evaluated by Western blot analysis. RESULTS: There was urethral fibrosis and to significant increase in collagen type I and III expressions in the urethral fibrosis group compared with the sham group (P <.05). Urethral injection of CCH appeared to be safe and significantly reduce urethral fibrosis as well as collagen type I and III expressions in the high-dose CCH treatment groups when compared with the treatment control group (P <.01). CONCLUSION: This study demonstrated a beneficial effect of CCH injections in a rat model of urethral fibrosis. These findings suggest a potential role for CCH as a therapeutic option in urethral stricture patients and warrant further investigation.
OBJECTIVE: To evaluate the treatment effect of collagenase Clostridium histolyticum (CCH) in a rat model of urethral fibrosis. MATERIALS AND METHODS: Thirty male Sprague-Dawley rats (300-350 g) were divided into 5 groups. The rat urethra was injected with normal saline in the sham group and, in the other 4 groups, the rat urethra was injected with 10 μg of transforming growth factor beta 1 to create fibrosis of the urethra. Two weeks following transforming growth factor beta 1 injection, the rats were injected with varying doses of CCH or vehicles, depending on their group. The rats were then euthanized at 4 weeks after CCH or vehicle injection. Urethral tissue was harvested for histologic and molecular analyses. Type I and III collagen levels were evaluated by Western blot analysis. RESULTS: There was urethral fibrosis and to significant increase in collagen type I and III expressions in the urethral fibrosis group compared with the sham group (P <.05). Urethral injection of CCH appeared to be safe and significantly reduce urethral fibrosis as well as collagen type I and III expressions in the high-dose CCH treatment groups when compared with the treatment control group (P <.01). CONCLUSION: This study demonstrated a beneficial effect of CCH injections in a rat model of urethral fibrosis. These findings suggest a potential role for CCH as a therapeutic option in urethral stricture patients and warrant further investigation.
Authors: K D Starkweather; S Lattuga; L C Hurst; M A Badalamente; F Guilak; S P Sampson; A Dowd; D Wisch Journal: J Hand Surg Am Date: 1996-05 Impact factor: 2.230
Authors: Premsant Sangkum; Ahmet Gokce; Ronny B W Tan; Mostafa Bouljihad; Hogyoung Kim; Sree Harsha Mandava; Sarmad N Saleem; George F Lasker; Faysal A Yafi; Zakaria Y Abd Elmageed; Krishnarao Moparty; Suresh C Sikka; Asim B Abdel-Mageed; Wayne J G Hellstrom Journal: J Urol Date: 2015-02-10 Impact factor: 7.450
Authors: E Alexsandro Da-Silva; Francisco J B Sampaio; M Cristina Dornas; Ronaldo Damiao; Luiz E M Cardoso Journal: J Urol Date: 2002-08 Impact factor: 7.450
Authors: Martin Gelbard; Irwin Goldstein; Wayne J G Hellstrom; Chris G McMahon; Ted Smith; James Tursi; Nigel Jones; Gregory J Kaufman; Culley C Carson Journal: J Urol Date: 2013-01-31 Impact factor: 7.450
Authors: Andre G Cavalcanti; Waldemar S Costa; Laurence S Baskin; Jack A McAninch; Francisco J B Sampaio Journal: BJU Int Date: 2007-08 Impact factor: 5.588
Authors: Jeffrey D Redshaw; Joshua A Broghammer; Thomas G Smith; Bryan B Voelzke; Bradley A Erickson; Christopher D McClung; Sean P Elliott; Nejd F Alsikafi; Angela P Presson; Michael E Aberger; James R Craig; William O Brant; Jeremy B Myers Journal: J Urol Date: 2014-09-06 Impact factor: 7.450
Authors: Yannick F Diehm; Dimitra Kotsougiani-Fischer; Elena Porst; Valentin Haug; Laura C Siegwart; Daniel Overhoff; Ulrich Kneser; Sebastian Fischer Journal: PLoS One Date: 2022-07-06 Impact factor: 3.752
Authors: Keerthi Atluri; Sathivel Chinnathambi; Alyssa Mendenhall; James A Martin; Edward A Sander; Aliasger K Salem Journal: Ann Biomed Eng Date: 2020-03-31 Impact factor: 3.934